What is the price target for AROC stock?
15 analysts have analysed AROC and the average price target is 39.55 USD. This implies a price increase of 8.93% is expected in the next year compared to the current price of 36.31.
NYSE:AROC • US03957W1062
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARCHROCK INC (AROC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-02 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-03-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-26 | Stifel | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-03 | Wells Fargo | Initiate | Overweight |
| 2025-08-29 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-08-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-03-18 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-02 | Mizuho | Initiate | Outperform |
| 2024-09-27 | Citigroup | Initiate | Buy |
| 2024-09-25 | Evercore ISI Group | Initiate | Outperform |
| 2024-09-06 | JP Morgan | Initiate | Overweight |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-24 | Stifel | Maintains | Buy -> Buy |
| 2024-05-02 | Stifel | Maintains | Buy -> Buy |
| 2024-03-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 990.337M 17.12% | 1.158B 16.89% | 1.49B 28.70% | 1.593B 6.93% | 1.679B 5.40% | 1.794B 6.85% | 1.847B 2.95% | 1.935B 4.76% | 1.997B 3.20% | |
| EBITDA YoY % growth | 423.593M 37.95% | 558.408M 31.83% | 832.148M 49.02% | 915.63M 10.03% | 974.2M 6.40% | 1.056B 8.40% | 1.124B 6.44% | 1.186B 5.52% | 1.232B 3.88% | |
| EBIT YoY % growth | 257.352M 80.22% | 365.214M 41.91% | 575.387M 57.55% | 625.19M 8.66% | 670.35M 7.22% | 743.79M 10.96% | N/A | N/A | N/A | |
| Operating Margin | 25.99% | 31.55% | 38.62% | 39.25% | 39.93% | 41.46% | N/A | N/A | N/A | |
| EPS YoY % growth | 0.67 123.33% | 1.05 56.72% | 1.87 78.10% | 1.99 6.57% | 2.20 10.30% | 2.57 16.87% | 3.01 17.13% | 3.35 11.19% | 3.62 8.23% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.48 16.49% | 0.48 22.33% | 0.50 26.16% | 0.52 -23.04% | 0.70 47.36% | 0.71 48.58% | 0.74 46.54% | 0.75 46.39% |
| Revenue Q2Q % growth | 388.67M 11.96% | 399.54M 4.28% | 403.01M 5.38% | 402.43M 6.72% | 410.44M 5.60% | 422.82M 5.83% | 420.93M 4.45% | 420.57M 4.51% |
| EBITDA Q2Q % growth | 221.95M 19.60% | 227.33M -13.01% | 230.32M -30.56% | 232.42M -44.64% | 237.4M 6.96% | 241.61M 6.28% | 243.2M 5.59% | 246.01M 5.85% |
| EBIT Q2Q % growth | 148.65M 16.17% | 152.61M 8.56% | 155.82M 8.35% | 156.67M -3.90% | 159.09M 7.02% | 161.44M 5.79% | 163.81M 5.13% | 166.2M 6.08% |
All data in USD
15 analysts have analysed AROC and the average price target is 39.55 USD. This implies a price increase of 8.93% is expected in the next year compared to the current price of 36.31.
ARCHROCK INC (AROC) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of ARCHROCK INC (AROC) is 0.48 USD and the consensus revenue estimate is 388.67M USD.
The consensus rating for ARCHROCK INC (AROC) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.